Both enantiomers of the epibatidine analogue flubatine display high affinity towards the α4β2 nicotinic acetylcholine receptor (nAChR) in vitro, accompanied by negligible interactions with diverse off-target proteins. Extended single dose toxicity studies in rodent indicated a NOEL (No Observed Effect Level) of 6.2μg/kg for (-)-flubatine and 1.55μg/kg for (+)-flubatine. We developed syntheses for both flubatine enantiomers and their corresponding precursors for radiolabeling. The newly synthesized trimethylammonium precursors allowed for highly efficient (18)F-radiolabelling in radiochemical yields >60% and specific activities >750GBq/μmol, thus making the radioligands practical for clinical investigation.
Keywords: 2-[(18)F]FA; 2-[(18)F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine; 5-[(123)I]-5-iodo-3-(2(S)-azetidinylmethoxy)pyridine; 5-[(123)I]IA; AD; Alzheimers’s disease; Alzheimers’s disease (AD); Flubatine; Fluorine-18; HPLC; Nicotinic acetylcholine receptor (nAChR); PET; PSL/mm(2); ROI; high performance liquid chromatography; nAChR; nicotinic acetylcholine receptor; p.s.; particle size; photostimulated luminescence per area; positron emission tomography; regions of interest.
Copyright © 2013 Elsevier Ltd. All rights reserved.